Graviti Pharmaceuticals Private Limited: Drug Recall
Recall #D-0037-2026 · 09/15/2025
Class II: Risk
Recall Details
- Recall Number
- D-0037-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Graviti Pharmaceuticals Private Limited
- Status
- Ongoing
- Date Initiated
- 09/15/2025
- Location
- Hyderabad, India
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 46,512/30 count bottles
Reason for Recall
Failed Tablet/Capsule Specifications
Product Description
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.
Distribution Pattern
Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
Other Recalls by Graviti Pharmaceuticals Private Limited
- Class II: Risk 01/10/2026
View all recalls by Graviti Pharmaceuticals Private Limited →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.